Health professionals: ICVP printing issue – action required
A batch of the 2024 International Certificate of Vaccination or Prophylaxis has a printing error
UKHSA publishes 2022 and 2023 UK malaria cases in returned travellers
Malaria risk reminder for travellers and health professionals as UK Health Security Agency confirm 2022 and 2023 imported UK malaria cases in England, Wales and Northern Ireland
ICC Men's T20 Cricket World Cup 2024
Tournament in June 2024 will be co-hosted in the West Indies and the USA
‘Getting to grips with tick-borne encephalitis’ webinar video available
The recording of the tick-borne encephalitis webinar on 28 March 2024 now added to TravelHealthPro
Travelling to Germany for Euro 2024?
Travel health advice for fans going to the 2024 Euros
Yellow fever update
Yellow fever cases continue to be reported in Africa and South America
Polio: Public Health Emergency of International Concern
An update on the polio Public Health Emergency of International Concern (PHEIC)
Qdenga® dengue vaccine guidance
Joint Committee on Vaccination and Immunisation (JCVI) deliberations on Qdenga® vaccine now available
Yellow fever pre-vaccination checklist updated
Updates to the pre-vaccination checklist have been made in line with the new 'green book' yellow fever chapter
Nipah virus; information for travellers and health professionals
Information on risks and prevention for travellers and health professionals
Cholera in Brazil
On 19 April 2024, the first locally acquired cholera (Vibrio cholerae O1 Ogawa) case in Brazil since 2005 was confirmed. A resident of Salvador, presented with symptoms in March 2024 with no history of travel to risk countries or contact with suspected or confirmed cases. Cholera is rare in travellers, a vaccine is available for those who are at increased risk.
Lassa fever in Nigeria
As of 22 April 2024, 5,669 suspected, 832 confirmed and 17 probable cases, including 152 deaths, have been reported. In total for 2024, 27 states have recorded at least 1 confirmed case across 126 Local Government Areas.
Shigellosis in Belgium, Germany, Ireland & Netherlands
On 9 April 2024, 31 cases of extensively drug-resistant (XDR) Shigella sonnei infections were reported in Belgium since January 2024. On 12 April 2024, cases were also reported from Germany (2), Ireland (2), and the Netherlands (1). All of the cases had links to a music festival in Belgium.
Botox reaction in USA
As of 12 April 2024, a total of 19 people from nine states have reported harmful reactions after receiving botulinum toxin injections from unlicensed or untrained individuals or in non-healthcare settings, such as homes and spas. Nine people have been admitted to hospital.
Cholera in Comoros
As of 14 April 2024, a total of 1,484 cholera cases, with 38 deaths (representing a 2.5% case mortality rate) have been reported since this cholera outbreak was declared on 2 February 2024. The three islands have reported cases, with most from Anjouan island.
Rabies in Timor-Leste
As of 22 March 2024, one fatal human case of rabies was confirmed in Pasabe Subregion, Oecusse. This is the first confirmed human case of rabies in Timor-Leste.
cVDPV2 in Liberia
As of 8 April 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) has been detected in an environmental sample in this country.
cVDPV2 in Senegal
As of 8 April 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) has been detected in an environmental sample in this country.
cVDPV2 in Sierra Leone
As of 8 April 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) has been detected in an environmental sample in this country.
Influenza A(H9N2) in Vietnam
As of 7 April 2024, the Vietnam Department of Information and Communications reported a confirmed human case of avian influenza A(H9N2) infection. This is the first confirmed human case of avian influenza A(H9N2) reported in Vietnam. To date, no further cases have been detected among close contacts.
